scholarly journals Science to Practice: Molecular-targeted Drug Delivery in Combination with Radiofrequency Ablation of Liver Cancer: A Magic Bullet?

Radiology ◽  
2017 ◽  
Vol 285 (2) ◽  
pp. 333-335 ◽  
Author(s):  
Lucas Christoph Adam ◽  
Nikitha Murali ◽  
Julius Chapiro ◽  
Jean-François Geschwind
2021 ◽  
Vol 104 ◽  
pp. 93-105
Author(s):  
Sikhumbuzo Charles Kunene ◽  
Kuen-Song Lin ◽  
Meng-Tzu Weng ◽  
Maria Janina Carrera Espinoza ◽  
Chun-Ming Wu

Biomaterials ◽  
2006 ◽  
Vol 27 (9) ◽  
pp. 2051-2059 ◽  
Author(s):  
Hsiang-Fa Liang ◽  
Chiung-Tong Chen ◽  
Sung-Ching Chen ◽  
Anandrao R. Kulkarni ◽  
Ya-Ling Chiu ◽  
...  

2022 ◽  
Vol 8 ◽  
Author(s):  
Lihong Gu ◽  
Feng Zhang ◽  
Jinhui Wu ◽  
Yuzheng Zhuge

Liver fibrosis is a reversible disease course caused by various liver injury etiologies, and it can lead to severe complications, such as liver cirrhosis, liver failure, and even liver cancer. Traditional pharmacotherapy has several limitations, such as inadequate therapeutic effect and side effects. Nanotechnology in drug delivery for liver fibrosis has exhibited great potential. Nanomedicine improves the internalization and penetration, which facilitates targeted drug delivery, combination therapy, and theranostics. Here, we focus on new targets and new mechanisms in liver fibrosis, as well as recent designs and development work of nanotechnology in delivery systems for liver fibrosis treatment.


2021 ◽  
Vol Volume 14 ◽  
pp. 1711-1724
Author(s):  
Ashagrachew Tewabe ◽  
Atlaw Abate ◽  
Manaye Tamrie ◽  
Abyou Seyfu ◽  
Ebrahim Abdela Siraj

Sign in / Sign up

Export Citation Format

Share Document